Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective
Ahmadi P, Ghandili S, Jakobs F, Konnopka C, Morgner-Miehlke A, Kröger N, Ayuk F
BONE MARROW TRANSPL. 2024;59(4):572-574.

Minimizing Long-Term Toxicities for Patients with Primary Mediastinal B-Cell Lymphoma Undergoing Modern Radiotherapy: Results from a Monocentric Biophysical Risk Evaluation: Cancers
Baehr A, Schäfer S, Jäckel M, Becker S, Ghandili S, Grohmann M, Eich H, Oertel M
2024 [Epub ahead of print].

A German perspective on the impact of socioeconomic status in diffuse large B-cell lymphoma
Ghandili S, Dierlamm J, Bokemeyer C, Kusche H, Peters F
BLOOD CANCER J. 2024;14(1):174.

The changing influence of neighborhood socioeconomic status on long-term survival in diffuse large B-cell lymphoma patients: A German metropolitan case-control study spanning over three decades
Ghandili S, Dierlamm J, Bokemeyer C, Kusche H, Peters F
HEMASPHERE. 2024;8(10):e70011.

Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sample
Kamili A, Ahmadi P, Leypoldt L, Marquard F, Schaefers C, Kosch R, Peters F, Kusche H, Zamrik T, Hanoun C, Seib M, Shumilov E, Leitner T, Khandanpour C, Bokemeyer C, Weisel K, Ghandili S
HAEMATOLOGICA. 2024;109(11):3795-3799.

Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch J, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U
ANN HEMATOL. 2024;103(5):1587-1599.

EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma
Akyüz N, Janjetovic S, Ghandili S, Bokemeyer C, Dierlamm J
VIRUSES-BASEL. 2023;15(9):.

VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience
Ghandili S, Alihodzic D, Wiessner C, Bokemeyer C, Weisel K, Leypoldt L
ANN HEMATOL. 2023;102(1):117-124.

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
Ghandili S, Dierlamm J, Bokemeyer C, von Bargen C, Weidemann S
FRONT ONCOL. 2023;13:1146029.

Therapie des nekrobiotischen Xanthogranuloms - Fallserie und aktuelle Literatur:
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1319.

Therapy of necrobiotic xanthogranuloma - case series and review of the literature
Hansen I, Ghandili S, Abeck F, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(11):1315-1318.

Letaler Verlauf einer Kryoglobulinämie Typ I
Hansen I, Ghandili S, Abeck F, Kött J, Booken N, Schneider S
J DTSCH DERMATOL GES. 2023;21(Suppl 2):15-18.

The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis
Modemann F, Ahmadi P, von Kroge P, Weidemann S, Bokemeyer C, Dierlamm J, Fiedler W, Ghandili S
LEUKEMIA LYMPHOMA. 2023;64(11):1801-1810.

Rezidivierte/refraktäre AML – Herausforderungen in Diagnostik und Therapie
Modemann F, Ghandili S, Bokemeyer C, Fiedler W
Kompendium ... Hämatologie/Onkologie. 2023;2023(21-27):21-27.

Therapie der rezidivierten/refraktären akuten myeloischen Leukämie: Aktuelle Behandlungsoptionen bei einem Rezidiv
Modemann F, Ghandili S, Bokemeyer C, Fiedler W
Im Fokus Onkologie. 2023;26(2):18-23.

Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis
von Kroge P, Duprée A, Mann O, Izbicki J, Wagner J, Ahmadi P, Weidemann S, Adjallé R, Kröger N, Bokemeyer C, Fiedler W, Modemann F, Ghandili S
WORLD J EMERG SURG. 2023;18(1):12.

Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation
Ghandili S, Kluger M, Leitner T, Grahammer F, Kirchner L, Modemann F, Achilles E, Kreipe H, Klein J, Steinemann D, Wolschke C, Fischer L, Bokemeyer C, Fiedler W, Huber T, Alsdorf W, Mahmud M
BRIT J HAEMATOL. 2022;198(1):199-202.

Clinical features of hepatitis E infections in patients with hematologic disorders
Ghandili S, Lindhauer C, Pischke S, Zur Wiesch J, Von Kroge P, Polywka S, Bokemeyer C, Fiedler W, Kröger N, Ayuk F, Adjallé R, Modemann F
HAEMATOLOGICA. 2022;107(12):2870-2883.

Aktueller diagnostischer Standard und Risikostratifizierung der AML
Ghandili S, Modemann F, Oelrich J, Bokemeyer C, Fiedler W
InFo Hämatologie + Onkologie. 2022;25(7-8):10–15.

Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment
Ghandili S, von Kroge P, Simon M, Henes F, Rohde H, Hoffmann A, Lindeman N, Bokemeyer C, Fiedler W, Modemann F
CANCERS. 2022;14(11):.

Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine
Klingler F, Alsdorf W, Ghandili S, Wolschke C, Brauneck F, Bokemeyer C, Fiedler W, Modemann F, Karagiannis P
LEUKEMIA LYMPHOMA. 2022;63(11):2645-2651.

Erstlinientherapie intensiv-therapierbarer AML Patient*innen
Modemann F, Ghandili S, Bokemeyer C, Fiedler W
InFo Hämatologie + Onkologie. 2022;25(7-8):16-21.

Therapie der akuten Promyelozytenleukämie
Modemann F, Ghandili S, Bokemeyer C, Fiedler W
InFo Hämatologie + Onkologie. 2022;25(12):16–21.

Überblick zur Diagnostik und Therapie neu diagnostizierter Patienten mit AML
Modemann F, Ghandili S, Bokemeyer C, Fiedler W
Onkologie heute. 2022;2022(09):22-29.

Aktuelle Therapieoptionen bei rezidivierter/refraktärer AML
Modemann F, Ghandili S, Oelrich J, Bokemeyer C, Fiedler W
InFo Hämatologie + Onkologie. 2022;25(10):18-23.

COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress
Modemann F, Ghandili S, Schmiedel S, Weisel K, Bokemeyer C, Fiedler W
CANCERS. 2022;14(15):.

Die akute Promyelozytenleukämie - ein hämatologischer Notfall
Modemann F, Ghandili S, Zhurba I, Langer F, Bokemeyer C, Fiedler W
InFo Hämatologie + Onkologie. 2022;25(12):10–15.

Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia-A Single Center Analysis
Modemann F, Härterich S, Schulze Zur Wiesch J, Rohde H, Lindeman N, Bokemeyer C, Fiedler W, Ghandili S
ANTIBIOTICS-BASEL. 2022;11(2):.

COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies
Modemann F, Niederwieser C, Weisel K, Bokemeyer C, Fiedler W, Ghandili S
LEUKEMIA LYMPHOMA. 2022;63(3):664-671.

Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study
Schönlein M, Wrage V, Ghandili S, Mellinghoff S, Brehm T, Leypoldt L, Utz N, Schrader R, Alsdorf W, Börschel N, Bußmann L, Schönrock M, Perlick D, Schön G, Verpoort K, Lütgehetmann M, Schulze Zur Wiesch J, Weisel K, Bokemeyer C, Schafhausen P, Sinn M
CANCER CELL. 2022;40(6):581-583.

Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment
Ghandili S, Schönlein M, Lütgehetmann M, Wiesch J, Becher H, Bokemeyer C, Sinn M, Weisel K, Leypoldt L
CANCERS. 2021;13(15):.

Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma
Ghandili S, Schönlein M, Wiessner C, Becher H, Lütgehetmann M, Brehm T, Wiesch J, Bokemeyer C, Sinn M, Weisel K, Leypoldt L
J CLIN MED. 2021;10(23):.

Current Treatment Approaches to Newly Diagnosed Multiple Myeloma
Ghandili S, Weisel K, Bokemeyer C, Leypoldt L
ONCOL RES TREAT. 2021;44(12):690-699.

Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
Ghandili S, Pfefferle S, Roedl K, Sonnemann P, Karagiannis P, Boenisch O, Kluge S, Schmiedel S, Ittrich H, Rohde H, Lütgehetmann M, Weisel K, Bokemeyer C, Wichmann D, Fiedler W, Jarczak D, Modemann F
BLOOD ADV. 2020;4(23):5936-5941.

The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature
von Kroge P, Bokemeyer F, Ghandili S, Bokemeyer C, Seidel C
ONCOL RES TREAT. 2020;43(10):549-558.

Pancreatic Metastasis from Endometrial Carcinoma
Ghandili S, Bardenhagen J, Izbicki J
J GASTROINTEST SURG. 2019;23(2):377-378.

Predictors of Long-term Success After Concomitant Surgical Ablation for Atrial Fibrillation
Pecha S, Ghandili S, Hakmi S, Willems S, Reichenspurner H, Wagner F
SEMIN THORAC CARDIOV. 2017;29(3):294-298.

Letzte Aktualisierung aus dem FIS: 23.12.2024 - 23:34 Uhr